Flannelly Barry P

Flannelly Barry P is listed in filings as Director at Protara Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 17, 2025, including sale activity. Recent filings connect the profile to Protara Therapeutics, Inc. (TARA) and Incyte Corp (INCY). The current snapshot covers public activity from Jan 17, 2025 to Jul 17, 2025. Reported amounts are shown as $78.2K to $1.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.